Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
9.73
+0.08 (0.83%)
At close: Nov 18, 2025, 4:00 PM EST
9.80
+0.07 (0.72%)
After-hours: Nov 18, 2025, 4:07 PM EST
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $529.01 million as of November 18, 2025. Its market cap has increased by 168.28% in one year.
Market Cap
529.01M
Enterprise Value
297.22M
1-Year Change
168.28%
Ranking
Category
Stock Price
$9.73
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $529.01M, an increase of 75.37%. That is a compound annual growth rate of 9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 522.24M | 106.00% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | 319.46M | -14.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |